Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: Jun 24, 2024
Date Accepted: Nov 5, 2024

The final, peer-reviewed published version of this preprint can be found here:

Feasibility and Efficacy of a Novel Mindfulness App Used With Matcha Green Tea in Generally Healthy Adults: Randomized Controlled Trial

Tanaka-Kanegae R, Yamada K, Cook CM, Blonquist TM, Taggart KD, Hamada K

Feasibility and Efficacy of a Novel Mindfulness App Used With Matcha Green Tea in Generally Healthy Adults: Randomized Controlled Trial

JMIR Mhealth Uhealth 2024;12:e63078

DOI: 10.2196/63078

PMID: 39657179

PMCID: 11668982

Feasibility and Efficacy of a Novel Mindfulness App Used with Matcha Green Tea in Generally Healthy Adults: Randomized Controlled Trial

  • Ryohei Tanaka-Kanegae; 
  • Koji Yamada; 
  • Chad M Cook; 
  • Traci M Blonquist; 
  • Kristen D Taggart; 
  • Koichiro Hamada

ABSTRACT

Background:

Mindfulness practices like breathing meditation (BM) are known to reduce stress and enhance mood. One such practice is mindful eating, where a practitioner focuses on the five senses while eating or drinking. A novel set of prototypes has been developed, incorporating principles of mindful eating. These prototypes include matcha green tea and a mobile application that provides audio guidance for meditation during the preparation and consumption of the beverage (hereafter referred to as guided tea meditation, GTM).

Objective:

This study aimed to investigate the adherence to GTM and its efficacy on stress levels and mood. Moreover, these outcomes were compared with traditional BM. Furthermore, other benefits of GTM were explored.

Methods:

This randomized, unblinded, controlled trial enrolled 100 healthy American volunteers (N=49 in the GTM and N=51 in the BM group). During the 8-week study period, participants were encouraged to perform either GTM or BM for 10 min daily. The meditation activity was self-reported the following day, and the time and frequency of meditation over eight weeks were evaluated to assess adherence. Stress levels were assessed using the Perceived Stress Scale-10, whereas changes in mood were assessed using the Two-Dimensional Mood Scale. Other benefits of meditation were explored using a questionnaire. An intention-to-treat (ITT) analysis was performed.

Results:

There were no significant between-group differences in the total time (P=.15) or frequency of meditation (P=.36). The GTM group exhibited a significant decrease in stress levels at week 4 and 8 (both P<.001), similar to the BM group. Moreover, improvements in several mood metrics after a single session of GTM were observed on day 1 and 56, and were comparable to those in the BM group. Meanwhile, increases from day 1 to day 56 in the pre-meditation scores for relaxed and calm were significantly higher among those who performed GTM (P=.04 and .048, respectively). The majority of participants assigned to GTM experienced positive changes in happiness, time management, quality of life, relationships, sleep, and work performance as they continued meditation. However, no significant between-group differences were found in these exploratory outcomes (P>.08).

Conclusions:

Adherence as the total meditation time and frequency over 8 weeks was not significantly different between GTM and BM. Meanwhile, GTM significantly reduced stress and improved mood, similar to BM. Long-term practitioners of GTM may even feel more relaxed and calmer at the state of pre-meditation than those who practice BM. Clinical Trial: ClinicalTrials.gov NCT05832645; https://clinicaltrials.gov/study/NCT05832645


 Citation

Please cite as:

Tanaka-Kanegae R, Yamada K, Cook CM, Blonquist TM, Taggart KD, Hamada K

Feasibility and Efficacy of a Novel Mindfulness App Used With Matcha Green Tea in Generally Healthy Adults: Randomized Controlled Trial

JMIR Mhealth Uhealth 2024;12:e63078

DOI: 10.2196/63078

PMID: 39657179

PMCID: 11668982

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.